{"id":7462,"date":"2025-06-30T15:02:41","date_gmt":"2025-06-30T15:02:41","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=7462"},"modified":"2025-06-30T15:02:41","modified_gmt":"2025-06-30T15:02:41","slug":"last-30-days-prevalence-of-drug-use-among-the-general-population-adults-aged-15-34-in-bulgaria","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/last-30-days-prevalence-of-drug-use-among-the-general-population-adults-aged-15-34-in-bulgaria\/","title":{"rendered":"Last 30 days prevalence of drug use among the general population (adults aged 15-34) in Bulgaria"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n
\n
Prevalence of psychoactive substance use
Prevalence of medication use
Prevalence of drug use<\/a>
Drug prevention
Treatment supply<\/a>
Treatment demand
Health consequences<\/a>
Harm reduction<\/a>
Drug-related crimes<\/a>
Drug market<\/a>
Drug use and prison<\/a>
Monitoring of publications<\/a>
Attitudes to legal framework changes<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Source: National population adult survey on attitudes and use of psychoactive substances among the general population (aged 15-64). The survey was conducted in the period October-November 2024 on behalf of and with the methodological support of the National Focal Point on Drugs and Drug Addictions by Sova 5 Agency, covering 4002 individuals (1269 individuals aged 15-34) across the country, and using the “face-to-face” method with a tablet. <\/p>\n<\/div>\n\n\n\n

\n

Last 30 days prevalence of drug use among the general population (adults aged 15-34) (by sex, 2024)<\/strong><\/p>\n\n\n\n

Type of drugs<\/strong><\/td>Males<\/strong><\/td>Females<\/strong><\/td>Total<\/strong><\/td>Interval (from)<\/strong><\/td>Interval (to)<\/strong><\/td><\/tr>
Any illegal drugs<\/strong><\/td>7.8%<\/strong><\/td>4.2%<\/strong><\/td>6.0%<\/strong><\/td>4.7%<\/strong><\/td>7.3%<\/strong><\/td><\/tr>
Cannabis (total)<\/strong><\/td>5.4%<\/strong><\/td>2.5%<\/strong><\/td>3.9%<\/strong><\/td>2.9%<\/strong><\/td>5.0%<\/strong><\/td><\/tr>
Herbal cannabis<\/td>5.1%<\/td>2.5%<\/td>3.8%<\/strong><\/td>2.7%<\/td>4.8%<\/td><\/tr>
Cannabis resin<\/td>1.9%<\/td>0.0%<\/td>0.9%<\/strong><\/td>0.4%<\/td>1.5%<\/td><\/tr>
Opioids (total)<\/strong><\/td>1.1%<\/strong><\/td>0.6%<\/strong><\/td>0.9%<\/strong><\/td>0.4%<\/strong><\/td>1.4%<\/strong><\/td><\/tr>
Heroin<\/td>0.8%<\/td>0.5%<\/td>0.6%<\/strong><\/td>0.2%<\/td>1.1%<\/td><\/tr>
Methadone<\/td>0.3%<\/td>0.2%<\/td>0.2%<\/strong><\/td>0.0%<\/td>0.5%<\/td><\/tr>
Other opioids (morphine, codeine)<\/td>0.3%<\/td>0.0%<\/td>0.2%<\/strong><\/td>0.0%<\/td>0.4%<\/td><\/tr>
Stimulants (total)<\/strong><\/td>2.2%<\/strong><\/td>1.4%<\/strong><\/td>1.8%<\/strong><\/td>1.1%<\/strong><\/td>2.5%<\/strong><\/td><\/tr>
Cocaine<\/td>0,8%<\/td>0,5%<\/td>0,6%<\/strong><\/td>0,2%<\/td>1,1%<\/td><\/tr>
Amphetamine<\/td>1,1%<\/td>0,6%<\/td>0,9%<\/strong><\/td>0,4%<\/td>1,4%<\/td><\/tr>
Methamphetamine<\/td>0,2%<\/td>0,3%<\/td>0,2%<\/strong><\/td>0,0%<\/td>0,5%<\/td><\/tr>
Ecstasy<\/td>1,1%<\/td>0,8%<\/td>0,9%<\/strong><\/td>0,4%<\/td>1,5%<\/td><\/tr>
Hallucinogens (total)<\/strong><\/td>0,0%<\/strong><\/td>0,2%<\/strong><\/td>0,1%<\/strong><\/td>0,0%<\/strong><\/td>0,2%<\/strong><\/td><\/tr>
LSD<\/td>0,0%<\/td>0,2%<\/td>0,1%<\/strong><\/td>0,0%<\/td>0,2%<\/td><\/tr>
Synthetic cannabinoids<\/strong><\/td>0.5%<\/strong><\/td>0.2%<\/strong><\/td>0.3%<\/strong><\/td>0.0%<\/strong><\/td>0.6%<\/strong><\/td><\/tr>
Inhalants<\/strong><\/td>0.5%<\/strong><\/td>0.0%<\/strong><\/td>0.2%<\/strong><\/td>0.0%<\/strong><\/td>0.5%<\/strong><\/td><\/tr>
Combination of two or more substances<\/strong><\/td>0.2%<\/strong><\/td>0.0%<\/strong><\/td>0.1%<\/strong><\/td>0.0%<\/strong><\/td>0.2%<\/strong><\/td><\/tr><\/tbody><\/table>
Note: The confidence interval is calculated on a 95% confidence level.<\/sub><\/figcaption><\/figure>\n\n\n\n

Last 30 days prevalence of drug use among the general population (adults aged 15-34) (by settlement, 2024)<\/strong><\/p>\n\n\n\n

Type of drugs<\/strong><\/td>Sofia (capital)<\/strong><\/td>District <\/strong>city<\/strong><\/td>Non-district city<\/strong><\/td>Village<\/strong><\/td>Total<\/strong><\/td><\/tr>
Any illegal drugs<\/strong><\/td>8.3%<\/strong><\/td>6.8%<\/strong><\/td>5.9%<\/strong><\/td>3.1%<\/strong><\/td>6.0%<\/strong><\/td><\/tr>
Cannabis (total)<\/strong><\/td>5.4%<\/strong><\/td>4.0%<\/strong><\/td>5.0%<\/strong><\/td>1.6%<\/strong><\/td>3.8%<\/strong><\/td><\/tr>
Herbal cannabis<\/td>4.7%<\/td>4.0%<\/td>5.0%<\/td>1.6%<\/td>3.8%<\/strong><\/td><\/tr>
Cannabis resin<\/td>2.2%<\/td>1.1%<\/td>0.3%<\/td>0.3%<\/td>0.9%<\/strong><\/td><\/tr>
Opioids (total)<\/strong><\/td>0.7%<\/strong><\/td>1.4%<\/strong><\/td>0.6%<\/strong><\/td>0.6%<\/strong><\/td>0.9%<\/strong><\/td><\/tr>
Heroin<\/td>0.4%<\/td>0.9%<\/td>0.6%<\/td>0.6%<\/td>0.6%<\/strong><\/td><\/tr>
Methadone<\/td>0.4%<\/td>0.6%<\/td>0.0%<\/td>0.0%<\/td>0.2%<\/strong><\/td><\/tr>
Other opioids (morphine, codeine) <\/td>0.4%<\/td>0.3%<\/td>0.0%<\/td>0.0%<\/td>0.2%<\/strong><\/td><\/tr>
Stimulants (total)<\/strong><\/td>3.2%<\/strong><\/td>2.6%<\/strong><\/td>0.9%<\/strong><\/td>0.6%<\/strong><\/td>1.8%<\/strong><\/td><\/tr>
Cocaine<\/td>0.7%<\/td>1.4%<\/td>0.0%<\/td>0.0%<\/td>0.6%<\/strong><\/td><\/tr>
Amphetamine<\/td>1.1%<\/td>1.7%<\/td>0.3%<\/td>0.3%<\/td>0.9%<\/strong><\/td><\/tr>
Methamphetamine<\/td>0.4%<\/td>0.3%<\/td>0.3%<\/td>0.0%<\/td>0.2%<\/strong><\/td><\/tr>
Ecstasy<\/td>2.2%<\/td>0.6%<\/td>0.9%<\/td>0.3%<\/td>0.9%<\/strong><\/td><\/tr>
Hallucinogens (total)<\/strong><\/td>0.0%<\/strong><\/td>0.0%<\/strong><\/td>0.1%<\/strong><\/td>0.0%<\/strong><\/td>0.1%<\/strong><\/td><\/tr>
LSD<\/td>0.0%<\/td>0.0%<\/td>0.1%<\/td>0.0%<\/td>0.1%<\/strong><\/td><\/tr>
Synthetic cannabinoids<\/strong><\/td>1.1%<\/strong><\/td>0.3%<\/strong><\/td>0.0%<\/strong><\/td>0.0%<\/strong><\/td>0.3%<\/strong><\/td><\/tr>
Inhalants<\/strong><\/td>0.0%<\/strong><\/td>0.3%<\/strong><\/td>0.3%<\/strong><\/td>0.3%<\/strong><\/td>0.2%<\/strong><\/td><\/tr>
Combination of two or more substances<\/strong><\/td>0.0%<\/strong><\/td>0.0%<\/strong><\/td>0.0%<\/strong><\/td>0.1%<\/strong><\/td>0.1%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Prevalence of psychoactive substance usePrevalence of medication usePrevalence of drug useDrug preventionTreatment supplyTreatment demandHealth consequencesHarm reductionDrug-related crimesDrug marketDrug use and prisonMonitoring of publicationsAttitudes to legal framework changes Source: National population adult survey on attitudes and use of psychoactive substances among the general population (aged 15-64). The survey was conducted in the period October-November 2024 on […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,86],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7462"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=7462"}],"version-history":[{"count":1,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7462\/revisions"}],"predecessor-version":[{"id":7463,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7462\/revisions\/7463"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=7462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=7462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=7462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}